Samsung E&A wins $354M contract to build Sartorius biopharma plant in Songdo

Samsung E&A secured a 518.6 billion-won ($354.2 million) contract to build a biopharmaceutical raw material production and research facility in Songdo, Incheon, for Sartorius AG. The plant will manufacture single-use bioprocessing bags and pharmaceutical membrane filters. Completion is scheduled for 2027.

“Samsung E&A Co. said Monday it has secured a 518.6 billion-won (US$354.2 million) contract to build a biopharmaceutical raw material production and research facility in Songdo.”en.yna.co.kr

• 1 source
• en.yna.co.krSamsung E&A wins 518.6 bln-won order to build Songdo plant for Sartorius AG | Yonhap News AgencyChang Dong-wooMar 24, 2025

Summarized from public sources; check the original articles before acting on it.